CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
High ImpactOriginal article

Lupin Receives U.S. FDA Approval for Modafinil Tablets, USP

RegulatoryapprovedModafinil Tablets, USPPositive
AI Analysis

Summary

Lupin Limited announced U.S. FDA approval for Modafinil Tablets, USP, a generic pharmaceutical product. The approval marks regulatory clearance for the company's modafinil formulation in the U.S. market.

Outcome Details

U.S. FDA approval for Modafinil Tablets, USP

Importance:8/10
Sentiment:
0.90
FDA approvalgeneric drugmodafinil
Related Companies

Read the original article

Published by PR Newswire Biotech on September 4, 2026 5:42 PM

Read Original